Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Having a healthy gut is key as it permits the body to build a stronger immune system
Cipla and Ethris partner for the development of mRNA-based therapies
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Company to open new headquarters in 2024
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas
Subscribe To Our Newsletter & Stay Updated
